Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Condition: Relapsed / Refractory Mantle Cell Lymphoma (MCL)
NCT04398953
A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.